What are the precautions with proton pump inhibitor use for reflux disease?

被引：2

作者：

Mospan, Cortney M. ^{[1
,2
]}

机构：

[1] E Tennessee State Univ, Bill Gatton Coll Pharm, Pharm Practice, Johnson City, TN 37614 USA

[2] Univ Charitable Pharm, Columbus, OH USA

来源：

JAAPA-JOURNAL OF THE AMERICAN ACADEMY OF PHYSICIAN ASSISTANTS | 2015年 / 28卷 / 12期

关键词：

gastroesophageal reflux disease; proton pump inhibitor; comorbidities; older adults; clopidogrel; fractures; THERAPY; SAFETY;

D O I：

10.1097/01.JAA.0000473372.47749.16

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Gastroesophageal reflux disease (GERD) affects 10% to 20% of the western world's population. Current treatment guidelines recommend proton pump inhibitors (PPIs) as first-line therapy. Although PPIs cause mild adverse reactions, they pose risks, particularly for older adults with comorbidities.

引用

页码：23 / 26

页数：3

共 50 条

[11] Reflux symptoms and reflux disease. Does it always have to be a proton pump inhibitor?
Labenz, Joachim
GASTROENTEROLOGIE, 2024,
[12] Dysphagia associated with gastroesophageal reflux disease is improved by proton pump inhibitor
Oda, K
Iwakiri, R
Hara, M
Watanabe, K
Danjo, A
Shimoda, R
Kikkawa, A
Ootani, A
Sakata, H
Tsunada, S
Fujimoto, K
DIGESTIVE DISEASES AND SCIENCES, 2005, 50 (10) : 1921 - 1926
[13] Dysphagia Associated with Gastroesophageal Reflux Disease Is Improved by Proton Pump Inhibitor
Kayoko Oda
Ryuichi Iwakiri
Megumi Hara
Kazuyo Watanabe
Akiko Danjo
Ryo Shimoda
Atsushi Kikkawa
Akifumi Ootani
Hiroyuki Sakata
Seiji Tsunada
Kazuma Fujimoto
Digestive Diseases and Sciences, 2005, 50 : 1921 - 1926
[14] Overview of pediatric gastroesophageal reflux disease and proton pump inhibitor therapy
Colletti, RB
Di Lorenzo, C
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2003, 37 : S7 - S11
[15] Endoscopic gastroplication for proton pump inhibitor refractory gastrooesophageal reflux disease
Lynch, PM
Tham, TCK
GUT, 2005, 54 : A68 - A69
[16] Gastroesophageal Reflux Disease or Proton Pump Inhibitor Use? A Controversy Over the Association of Nontuberculous Mycobacterial Pulmonary Disease
Kagawa, Tomoko
Nagano, Hiroyuki
Iwasaku, Masahiro
Kawano, Reo
Hirayama, Yoji
Uraguchi, Kensuke
Yoshioka, Takashi
CHEST, 2023, 163 (03) : E147 - E148
[17] (IN)APPROPRIATE USE OF PROTON PUMP INHIBITORS IN GASTROESOPHAGEAL REFLUX DISEASE
Elkhouly, Mohamed
Kotwal, Vikram
Attar, Bashar M.
Trick, William
Diep, Lisa
GASTROENTEROLOGY, 2018, 154 (06) : S239 - S239
[18] Does Helicobacter pylori eradication or proton pump inhibitor use benefit gastroesophageal reflux disease? Reply
Moschos, John M.
Kouklakis, George
Zavos, Christos
Kountouras, Jannis
ANNALS OF GASTROENTEROLOGY, 2015, 28 (02): : 294 - 295
[19] COST BURDEN OF INAPPROPRIATE PROTON-PUMP INHIBITOR USE AMONG GASTROESOPHAGEAL REFLUX DISEASE PATIENTS
Rane, P.
Guha, S.
Garey, K.
Chen, H.
Johnson, M. L.
Aparasu, R.
VALUE IN HEALTH, 2016, 19 (03) : A314 - A314
[20] What is the place of empirical proton pump inhibitor testing in the diagnosis of gastroesophageal reflux disease? (Description, duration, and dosage)
Vardar, Rukiye
Keskin, Muharrem
TURKISH JOURNAL OF GASTROENTEROLOGY, 2017, 28 : S12 - S15

← 1 2 3 4 5 →